ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
29 juil. 2024 07h45 HE
|
ZyVersa Therapeutics
Plasma levels of inflammasome ASC show promise as a biomarker of early cognitive decline in older adults.
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority
03 janv. 2024 09h46 HE
|
Spherix Global Insights
EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Huntington’s disease (HD) could be called the perfect storm of neurodegenerative diseases. It causes a loss of critical striatal neurons which affect not...
AAPA, PA Foundation, Cleveland Clinic, and Davos Alzheimer’s Collaborative Release Early Cognitive Assessment Toolkit
01 nov. 2023 09h26 HE
|
American Academy of PAs
ALEXANDRIA, VA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), PA Foundation (PAF), Cleveland Clinic, and Davos Alzheimer’s Collaborative (DAC) today publicly...
Collaborative AAPA, PA Foundation, Cleveland Clinic Alzheimer’s Early Detection Project Moves into Pilot Phase
28 juin 2023 10h59 HE
|
American Academy of PAs
Alexandria, VA, June 28, 2023 (GLOBE NEWSWIRE) -- Last year, the American Academy of PAs (AAPA), the PA Foundation, and Cleveland Clinic were awarded a grant from the Davos Alzheimer’s Collaborative...
VAGA Helps People Suffering with Poor Mental Health or Cognitive Decline Through Art Therapy
13 juin 2022 09h00 HE
|
Vaga
New York, June 13, 2022 (GLOBE NEWSWIRE) -- Mental health is a topic that has been under the spotlight in recent years, as people are realising that it is just as important as physical health and...
Cognitive Decline Market is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031)
25 avr. 2022 09h00 HE
|
Persistence Market Research
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to...
Don’t Surrender to Cognitive Aging and Dementia
20 déc. 2017 08h00 HE
|
Posit Science
SAN FRANCISCO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Dr. Henry Mahncke, CEO of Posit Science, commented on a group of review articles published yesterday, which claimed no intervention of any kind has...